Personalized medicine trial aims to slow kidney failure
NCT ID NCT07239570
Summary
This study is testing if a personalized treatment plan, guided by simple urine tests, can better protect kidney function compared to standard care. It will enroll 125 adults with chronic kidney disease and protein in their urine. Researchers will use the test results to decide which of three newer kidney-protective medications to give, and in what order, to try and slow the disease most effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Clinico de Valencia
NOT_YET_RECRUITINGValencia, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Lund University
NOT_YET_RECRUITINGMalmo, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Steno Diabetes Center Copenhagen
RECRUITINGHerlev, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Medical Center Hamburg-Eppendorf
NOT_YET_RECRUITINGHamburg, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.